Stay updated on Pembrolizumab in Mets Melanoma: (C11-AMT) PET Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab in Mets Melanoma: (C11-AMT) PET Clinical Trial page.

Latest updates to the Pembrolizumab in Mets Melanoma: (C11-AMT) PET Clinical Trial page
- ChecktodayChange DetectedThe page's related topics/MeSH terms section has been updated to remove Melanoma, related topics:, and MedlinePlus Genetics; this changes how the study is indexed for topic-based searches without altering the study details themselves.SummaryDifference0.1%

- Check8 days agoChange DetectedA new revision entry was added: v3.5.4, replacing the previous v3.5.3. This represents a minor update to the page's revision metadata without altering shown trial content or functionality.SummaryDifference0.0%

- Check15 days agoChange DetectedMelanoma was added as an additional relevant MeSH term and MedlinePlus Genetics was added as a related topic, improving indexing and discoverability of the study.SummaryDifference0.1%

- Check22 days agoChange DetectedRemoved Melanoma from the page's additional MeSH terms and deleted the Related topics heading and MedlinePlus Genetics reference, altering how the study is categorized and linked to genetics resources.SummaryDifference0.1%

- Check29 days agoChange DetectedThe page’s footer/module metadata was updated to reflect new related-topic listings (MedlinePlus/Genetics) and a site revision version, with no change to the underlying study record content.SummaryDifference0.2%

- Check36 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

Stay in the know with updates to Pembrolizumab in Mets Melanoma: (C11-AMT) PET Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Mets Melanoma: (C11-AMT) PET Clinical Trial page.